title: Regular use of margarine-containing stanol/sterol esters reduces total and low-density lipoprotein (LDL) cholesterol and allows reduction of statin therapy after cardiac transplantation: preliminary observations.
abstract: Seventeen stable cardiac transplant recipients, of whom 16 were on statin therapy, used margarine with stanol/sterol esters. Total cholesterol in the treatment group was lowered from 211 mg/dl (range 168 to 244) to 177 mg/dl (136 to 241) (17% reduction, p = 0.003) and low-density lipoprotein (LDL) cholesterol was reduced from 125 mg/dl (73 to 161) to 98 mg/dl (57 to 146) (22% reduction, p = 0.0006). LDL cholesterol reached the pre-defined cut-off level of 115 mg/dl in 12 of 17 patients and statin dosages were reduced. In 8 of 12 patients, LDL cholesterol remained at <115 mg/dl 6 weeks after statin reduction.
authors.affiliation: Department of Cardiology, University Hospital of Antwerp, Edegem, Belgium. anne.vorlat@uza.be
authors.forename: Anne
authors.initials: A
authors.lastname: Vorlat
authors.forename: Viviane M
authors.initials: VM
authors.lastname: Conraads
authors.forename: Christiaan J
authors.initials: CJ
authors.lastname: Vrints
mesh_terms: D000328:Adult; D000368:Aged; D002784:Cholesterol / Q000097:blood*; D008078:Cholesterol, LDL / Q000097:blood*; D018680:Cholinergic Antagonists / Q000008:administration & dosage; D004035:Diet Therapy; D016027:Heart Transplantation; D006801:Humans; D007165:Immunosuppression Therapy; D008297:Male; D008383:Margarine; D008875:Middle Aged; D010840:Phytosterols / Q000627:therapeutic use
chemical_list: D008078:Cholesterol, LDL; D018680:Cholinergic Antagonists; D010840:Phytosterols; D008383:Margarine; D002784:Cholesterol